Cromos Pharma continues to battle COVID-19 It has been over two and a half years since the COVID-19 pandemic began. Its effects have been far-reaching, and many economies and societies around the world came to a standstill, but there was an even higher price to be paid. In a relatively short amount of time, almost 6,5 million people died from this
Cromos Pharma Highlights Psoriasis Awareness and Action Month August is Psoriasis Awareness and Action Month, which is aimed to educate people about psoriasis and to enlighten patients about its triggers and treatment methods. Cromos Pharma is using this opportunity to underline its commitment to supporting clinical trials to develop new and innovative treatments to improve the lives of millions of psoriasis sufferers around the world. Psoriasis
Monkeypox was Declared a Global Health Emergency by WHO Recently the world has faced an epidemiological threat called monkeypox. This disease is not new and began to spread in Africa in the 1970s. Monkeypox is a viral zoonotic disease, which means that the virus is transmitted from animals to people, and then spreads from person to person by close physical contact with lesions, contaminated
